79074243 - MTM

Information

• Trademark
• 79074243

• Source

• Serial Number

  79074243

• Registration Number

  3818640

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 05, 2009
  15 years ago

• Registration Date

  July 13, 2010
  14 years ago

• Transaction Date

  March 07, 2020
  4 years ago

• Status Date

  August 05, 2019
  5 years ago

• Published for Opposition Date

  April 27, 2010
  14 years ago

• Location Date

  July 13, 2010
  14 years ago

• Status Code

  404

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HOLTZ, ALLISON A

• Attorney Name

  JAMES R. CADY

  Law Office Assigned Location Code

  M20

• Owners

  • MTM Laboratories AG
  • Roche Holding AG

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of "MTM" with circular belt.
• GS0011: Chemicals used in industry and science, diagnostic preparations, reagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use
• GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
• GS0101: Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipment, namely, containers specially designed for storing and transporting medical samples in the nature of tubes, multiwell plates, columns, strips, sticks and brushes, and medical syringes, needles for medical use, spatulas for medical samples and medical diagnostic testing, and medical diagnostic testing swabs, cloths and tampons, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above; medical diagnostic nucleic acid detection machines, medical diagnostic nucleic acid amplification machines, medical diagnostic immuno-histology machines and medical diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above for clinical and medical laboratory use
• GS0421: Scientific and technological services and research and design relating thereto in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics; industrial analysis and research services in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics, design and development of computer hardware and software, scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services
• GS0441: Medical services, veterinary services, medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Case File Event Statements

• 3/6/2020 - 4 years ago

  36 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC

• 3/6/2020 - 4 years ago

  35 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 11/17/2017 - 6 years ago

  34 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 10/19/2017 - 6 years ago

  33 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 10/19/2017 - 6 years ago

  32 - INVALIDATION PROCESSED Type: INPC

• 10/17/2017 - 6 years ago

  31 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 2/17/2017 - 7 years ago

  30 - CANCELLED SECTION 71 Type: C71T

• 2/13/2013 - 11 years ago

  29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 3/2/2012 - 12 years ago

  28 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 10/22/2010 - 13 years ago

  27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/22/2010 - 13 years ago

  26 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/14/2010 - 13 years ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/13/2010 - 14 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/27/2010 - 14 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/27/2010 - 14 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/22/2010 - 14 years ago

  21 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 3/18/2010 - 14 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/4/2010 - 14 years ago

  19 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR

• 2/22/2010 - 14 years ago

  18 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 2/22/2010 - 14 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/22/2010 - 14 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/22/2010 - 14 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 1/22/2010 - 14 years ago

  14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/22/2010 - 14 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/25/2009 - 14 years ago

  12 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/1/2009 - 14 years ago

  11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/1/2009 - 14 years ago

  10 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/1/2009 - 14 years ago

  9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 11/30/2009 - 14 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/27/2009 - 14 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR

• 11/26/2009 - 14 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 11/25/2009 - 14 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/21/2009 - 14 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/17/2009 - 14 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/17/2009 - 14 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 11/12/2009 - 14 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR